Skip to main content
. 2023 Jul 12;14:1188969. doi: 10.3389/fendo.2023.1188969

Figure 4.

Figure 4

(A) Mean difference of BMD in the lumbar spine at 12 months from baseline between denosumab and romosozumab. (B) Mean difference of BMD in the femoral neck at 12 months from baseline between denosumab and romosozumab. (C) Mean difference of BMD in the total hip at 12 months from baseline between denosumab and romosozumab. (D) Mean difference of P1NP at 12 months from baseline between denosumab and romosozumab. (E) Mean difference of TRACP-5b at 12 months from baseline between denosumab and romosozumab. BMD, bone mineral density; DENO, denosumab; ROMO, romosozumab.